Related Articles
Comparison of calculated body muscle mass and SARC‑F as methods of screening for sarcopenia in patients with chronic liver disease
Indices calculated by serum creatinine and cystatin C as predictors of liver damage, muscle strength and sarcopenia in liver disease
Effect of levocarnitine administration in patients with chronic liver disease
Prognostic significance of sarcopenia in patients with hepatocellular carcinoma undergoing sorafenib therapy
Negative impact of sarcopenia on survival in elderly patients with colorectal cancer receiving surgery: A propensity‑score matched analysis